[DOI] [PMC free article] [PubMed] [Google Scholar] 73.Magalhes P.V., Dean O.M., Bush A.I., Copolov D.L., Malhi G.S., Kohlmann K.K., Jeavons S., Schapkaitz I., Anderson-Hunt M.D., Berk M
No new safety signals were identified, and no hypoglycemia was reported
Hormonal status, baseline tissue volume, age, and the rate of weight loss all influence how perceptible any change becomes
Contact us today to learn more about GLP-1 medications and how they may fit into a comprehensive weight loss plan
However, the evidence for meaningful clinical benefit in elderly populations remains preliminary, and the risk-benefit calculation must account for potential effects on glucose metabolism and cancer risk
DyallSCBalasLBazanNGBrennaJTChiangNda Costa SouzaFet al